Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79c69d6fd638eeef6678ba835bd1f21e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
filingDate |
2021-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83dd187afad7f841dfccb83257a073af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48ad31f51caddc977cb0d04cfba2cf49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8a123745e5fbe340d393ae150518c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa452abde29b91ee02db927f361e384 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7cb73f5ff146380b2c01efca20a69e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f45b9bd5e4827abffde5f64d9d950e9 |
publicationDate |
2022-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022020585-A1 |
titleOfInvention |
Process for making an isoxazoline compound and intermediate thereof |
abstract |
The present disclosure provides processes for making enantiomerically pure isoxazoline compounds of formula (1), (1). The present disclosure also provides processes for making enantiomerically pure isoxazoline compounds of formula (1) characterized by improving the enantiomeric purity of 3-methyl-5-[(5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]thiophene-2-carboxylic acid by crystallization. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115594645-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115504971-A |
priorityDate |
2020-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |